CompletedPhase 4

Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases

120 participantsStarted 2013-01

Plain-language summary

Comparison of efficacy of H.pylori eradication during first line therapy using standard or high doses of omeprazole administered twice daily in combination with amoxicillin and clarithromycin for 10 days.

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of both sexes between the ages of 18 and 75 years old, ready to sign informed consent and and agree to follow all requirements of study protocol. * The patient should be prepared to fill out questionnaires on their own wedge and symptoms. * Non pregnant, not nursing patient. * Patients must be either n of stklimaktericheskom period, or surgically sterile, or throughout the study period using contraceptive methods, the reliability of more than 90%. - Contraceptive methods with the reliability of more than 90% of the normal used e of include the cervical cap with spermicide, diaphragm with spermicide, condoms, oral contraceptives, intrauterine devices, acetate HCWs to siprogesterona and levonorgestrel subdermal implants; Exclusion Criteria: * A history of surgery performed to reduce gastric acid secretion in the stomach or esophagus to operations and / or upper digestive tract. * The presence of obstructive strictures or esophageal ulcers, varicose veins vehi ie water, esophageal achalasia. * Barrett's esophagus. * patients taking other medications for GERD over a period of two weeks or PPIs during the preceding and a following of the month. * Zollinger-Ellison syndrome . * Peptic ulcer and 12 duodenal ulcer in acute * erosive gastro. * Cancer of the stomach or esophagus. * Coronary heart disease. * Colic disease. * Chronic pancreatitis. * Gallstone disease. * Pyloric stenosis. * Regular intake of steroids or any other drugs ulcerogenic, n as a…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

H Pylori eradicaion rates

Timeframe: Baseline to 6 weeks

Trial details

NCT IDNCT02922699

SponsorDr. Reddy's Laboratories Limited

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2013-06

View on ClinicalTrials.gov More GERD trials

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.